A37 N-803 Plus Nivolumab for Advanced or Metastatic Non-Small Cell Lung Cancer: Update on Phase II Experience of Combination PD1 Blockade with an IL-15 Superagonist
Autor: | Wrangle, J., Velcheti, V., Patel, M., Sweiderska-syn, M., Macpherson, L., Coggins, C., Kreig, C., Redmond, W., Rock, A., Lee, J., Rubinstein, M. |
---|---|
Zdroj: | In Journal of Thoracic Oncology February 2020 15(2) Supplement:S24-S25 |
Databáze: | ScienceDirect |
Externí odkaz: |